Previous Article | Next Article 
Infection and Immunity, September 2001, p. 5305-5312, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5305-5312.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Role of Trehalose Dimycolate in Recruitment of Cells
and Modulation of Production of Cytokines and NO in
Tuberculosis
Valéria M. F.
Lima,1
Vania L. D.
Bonato,1
Karla M.
Lima,1
Sandra A.
Dos
Santos,1
Rubens R.
Dos
Santos,1
Eduardo D. C.
Gonçalves,1
Lucia H.
Faccioli,2
Izaira T.
Brandão,1
José M.
Rodrigues-Junior,3 and
Célio L.
Silva1,*
Department of Biochemistry and Immunology,
School of Medicine of Ribeirão Preto,1 and
School of Pharmacy of Ribeirão
Preto,2 University of São Paulo,
Ribeirão Preto, SP, and Faculty of Pharmacy, Federal
University of Minas Gerais, Belo Horizonte, MG,3
Brazil
Received 18 September 2000/Returned for modification 4 December
2000/Accepted 29 May 2001
 |
ABSTRACT |
Mice treated with viable Mycobacterium
tuberculosis with no glycolipid trehalose dimycolate
(TDM) on the outer cell wall (delipidated M. tuberculosis)
by intraperitoneal or intratracheal inoculation presented an intense
recruitment of polymorphonuclear cells into the peritoneal cavity and
an acute inflammatory reaction in the lungs, respectively. In addition,
lung lesions were resolved around the 32nd day after intratracheal
inoculation. TDM-loaded biodegradable poly-DL-lactide-coglycolide microspheres as well as
TDM-coated charcoal particles induced an intense inflammatory
reaction. In addition, high levels of interleukin-6 (IL-6), tumor
necrosis factor alpha (TNF-
), IL-12, IL-10, gamma
interferon (IFN-
), and IL-4 production were detected in lung cells,
and nitric oxide (NO) production was high in culture supernatants of
bronchoalveolar lavage cells. These in vivo data were confirmed
by in vitro experiments using peritoneal macrophages cultured in the
presence of TDM adsorbed onto coverslips. High levels of
IFN-
, IL-6, TNF-
, IL-12, IL-10, and NO were detected in the
culture supernatants. Our results suggest that TDM contributes to
persistence of infection through production of cytokines,
which are important for the recruitment of inflammatory cells and
maintenance of a granulomatous reaction. In addition, our
findings are important for a better understanding of the
immunostimulatory activity of TDM and its possible use as an
adjuvant in experiments using DNA vaccine or gene therapy against tuberculosis.
 |
INTRODUCTION |
Tuberculosis is a classical example
of an infectious illness in which the disease process is caused by the
immune response directed at the infectious agent. Innate and
cell-mediated immune responses directed against bacteria and their
products which are essentially nontoxic may lead to extensive
tissue damage, wasting, and death (24). On the other
hand, innate and cell-mediated responses also protect the
host against the disease by arresting, killing, and removing
multiplying bacteria. This effect determines disease progression by
regulating the supply of mycobacterial components that drive the
immunopathologic abnormalities (24). An important
question that arises from this balance between protective and
harmful effects of the immune response is whether distinct mycobacterial components could selectively induce protective responses and be suitable for use as new vaccines or immunotherapy for the disease.
Several factors which may have a role in the pathogenesis of disease
have been isolated from mycobacteria, including cord factor, a
component located at the external layer of the cell wall of
mycobacteria. The structure of cord factor has been fully elucidated by
Noll et al. (17), who showed that it was a glycolipid consisting of two mycolic acid molecules (an
-branched and
-hydroxylated fatty acid with 90 carbon atoms) linked to trehalose
by the hydroxyl groups of carbons 6 and 6', i.e., 6,6'-trehalose
dimycolate (TDM). Four decades of research on TDM have uncovered a
number of biological activities involved in the pathogenesis of
mycobacterial diseases, including high toxicity to mice
(3) and immunomodulation (12). Several other
effects of TDM in addition to its toxicity (28), such as
the development of a granulomatous reaction in mouse lungs after
intravenous administration (21), adjuvant and
immunostimulatory properties (10), and capacity to enhance
nonspecific resistance to tumors (12, 16) and to bacterial
infections (20, 22) in mice, suggest the participation of
TDM in the host-parasite relationship at different levels. Indirect
evidence has also been provided that TDM might be responsible for
inhibiting fusion between adjacent membranes in vivo (29),
suggesting a role in inhibition of phagosome-lysosomal fusion. More
recently, recognition of a glycolipid antigen by CD1-restricted

+ T cells has also been reported (2).
Protective immunity to mycobacteria is dependent on several effector
mechanisms working together, particularly at the infection's local
microenvironment. These factors include the local cell population and
its cytokine production and expression of adhesion (1) and
costimulatory molecules. Local cytokines produced by inflammatory cells
are thought to direct macrophage activation and T-cell development to a
Th1 or Th2 pattern on the following days of infection, leading to
control of antibacterial activity (18). Evasion of innate defense mechanisms and cell-mediated immunity are the keys to the
success of Mycobacterium tuberculosis, and this
microorganism must adapt to the intracellular environment in the
macrophage (24). How is this immune response altered
or manipulated by M. tuberculosis or its products
so that it can up- or down-regulate the expression of cytokine
molecules in the host? To help answer this question, we have used in
the present study a model of pulmonary and intraperitoneal (i.p.)
M. tuberculosis infection with no glycolipid TDM on the
outer cell wall (delipidated M. tuberculosis) or
TDM-loaded biodegradable poly-DL-lactide-coglycolide (PLGA)
microspheres to study the local inflammatory events and establish the
relationship of the nature and extent of the inflammatory reaction to
cytokine production.
 |
MATERIALS AND METHODS |
Live TDM-depleted M. tuberculosis.
The
depletion of TDM from live M. tuberculosis H37Rv was
carried out by treating the bacteria with petroleum ether (boiling point, 35 to 60°C) as previously described (4). The
viability of M. tuberculosis and solvent-treated
bacteria (delipidated M. tuberculosis) was determined
by plating serial fivefold dilutions of the bacterial suspension on
Lowestein Jensen agar at 37°C for 21 days. The residual
material extracted with petroleum ether contained several lipid
components, including glycolipids, free mycolic acid, glycerides,
menaquinones, and hydrocarbons. TDM, accounting for 90% of the
petroleum ether extract, had physical and chemical characteristics of
6,6'-dimycoloyl trehalose, as previously described (27).
TDM preparation.
One hundred grams of heat-killed, dried
M. tuberculosis H37Rv was repeatedly soaked in a
mixture of chloroform-methanol (1:1 [vol/vol]), and the extracted
residual material (18 g) was fractionated as previously reported for
TDM purification (27). The purified glycolipid (0.530 g)
migrated as a single band on thin-layer chromatography, similarly to
commercially available TDM (Sigma, St. Louis, Mo.).
TDM-loaded microspheres and TDM-coated charcoal particles.
Microspheres were prepared using the emulsion-solvent evaporation
technique (13, 14). Briefly, 5 mg of TDM (Sigma) and 125 mg of the biodegradable polymer PLGA (50:50) (Resomer RG 505; molecular
weight, 78,000; Boehringer Ingelheim, Mannheim, Germany) were
diluted in 30 ml of methylene chloride. This organic phase was mixed
with 100 ml of an aqueous phase containing 3% polyvinyl alcohol
(Mowiol 40-88; Sigma-Aldrich Chemicals) as surfactant to form a stable
oil-in-water emulsion. A 6-h stirring at room temperature with a
Eurostar homogenizer (600 rpm) was carried out to allow for organic
solvent evaporation. Microspheres were collected by centrifugation at
10,000 × g and washed three times with sterile water,
freeze-dried, and stored at 4°C. The presence of TDM was determined
by thin-layer chromatography after particle dissolution in methylene
chloride. Particle characterization was carried out by scanning
electron microscopy. Briefly, an aqueous suspension of microspheres was
dropped onto slides covered with poly-L-lysine (Sigma),
allowed to dry in air under ambient conditions, and stuck onto metal
stubs. Samples were coated with gold prior to examination by scanning
electron microscopy in a JSM-5200 scanning microscope (JEOL). Unloaded
PLGA microspheres, trehalose dibehenate (TDB) (Sigma), or unrelated
lipid control (a mixture of triglycerides; Sigma)-loaded PLGA
microspheres were prepared using the same procedure and used as
controls. TDM-coated charcoal particles (50 to 100 µm in diameter)
were prepared as previously described (26).
Animals, infection, and TDM-loaded microsphere and TDM-coated
charcoal particle administration.
Young adult BALB/c mice were
obtained from the vivarium of the School of Medicine of Ribeirão
Preto, University of São Paulo, and were maintained under
standard laboratory conditions. Mice were infected with 106
viable M. tuberculosis or delipidated M. tuberculosis cells intratracheal administration or with 3 × 106 organisms by i.p. administration under anesthesia using
200 µl of tribromoethanol (Sigma) in 2.5% phosphate-buffered saline
(PBS). Infected animals were kept in biohazard facilities and were
housed in cages within a laminar flow safety enclosure. Infected
animals were sacrificed at 2, 8, or 16 days for recruitment-of-cell
determinations and at 4, 16, or 32 days after infection for lung
inflammatory reaction characterization. Microspheres were administered
using the same route (200 mg/kg of body weight per mouse). Mice were sacrificed 60 days after microsphere treatment to allow for particle degradation and release of entrapped TDM. TDM-coated charcoal particles were administered by an intravenous route (100 µl) and sacrificed at different time points after injection. TDM or a lipid
control of TDB or a mixture of triglycerides was also injected by the
intravenous route (50 µg per animal).
Evaluation of lung granulomatous reaction and recruitment of
cells to the peritoneal cavity.
The ability of M. tuberculosis, delipidated M. tuberculosis,
TDM-PLGA microspheres, and TDM-coated charcoal particles to cause granulomatous reactions was assessed by histological analysis of the
lungs. Lung tissues from four mice per experimental group were infused
with fresh 10% formaldehyde in PBS at different times after each
treatment. Sections made from paraffin blocks were stained with
hematoxylin and eosin. Groups of five mice were injected i.p. with
3 × 106 viable M. tuberculosis or
delipidated M. tuberculosis cells or with 50 µg of
TDM. Control groups received PBS or lipid controls (TDB or a
mixture of triglycerides). At 2, 8, and 16 days after the injection of
stimulants the animals were killed with anesthetic and the cells from
the peritoneal cavities were harvested by injection of 3 ml of PBS
containing 5 µg of heparin/ml. The abdomens were gently massaged, and
a blood-free cell suspension was carefully withdrawn with a syringe.
Abdominal washings were placed in plastic tubes and total cell counts
were performed immediately in a Newbauer chamber. Differential counting
was obtained using Rosenfeld-stained cytospin preparations.
BALF.
Microsphere-treated mice were killed by an overdose of
sodium pentobarbitone (i.p.), and 1.0 ml of RPMI-1640 (Sigma) at room temperature was instilled through a polyethylene cannula introduced into the trachea. Cells present in the bronchoalveolar lavage fluid
(BALF) were recovered immediately. The procedure was repeated once.
Measurement of cytokines.
Levels of cytokines produced by
lung cells were measured by enzyme-linked immunosorbent assay (ELISA).
Total lung tissue was homogenized with an Ultraturrax T50 IKA
(Labortechnik, Staufen, Germany) apparatus for 5 min at 4°C.
Homogenized tissue was centrifuged at 10,000 × g for
15 min and the supernatant was filtered through a 0.22-µm-pore-size
Millipore filter. Capture and biotinylated monoclonal antibodies for
tumor necrosis factor alpha (TNF-
) (MP6-XT22, MP6-XT3),
interleukin-10 (IL-10) (JES5-2A5, JES5-16E3), IL-6 (MP5-20F3,
MP5-32C11), IL-4 (BVD4-1D11, BVD6-24G2), gamma interferon (IFN-
)
(R4-6A2, XMG1.2), and IL-12 (C15.6, C17.8) and recombinant cytokines
were purchased from Pharmingen (San Diego, Calif.). Levels of TNF-
,
IL-10, IL-6, IL-4, IFN-
, and IL-12 were determined in the
supernatants by ELISA as previously described (9)
following the manufacturer's instructions (Pharmingen). A standard
curve using preparations with known concentrations of mouse recombinant
TNF-
(rTNF-
), rIL-10, rIL-6, rIL-4, rIFN-
, or rIL-12,
respectively, was performed for each assay. The detection limit was 15 pg per ml for all cytokines evaluated. Lipopolysaccharide (LPS) (50 µg per mouse [100 µl])- and mock-injected mice were used as
positive and negative controls, respectively. TDB or a mixture of
triglyceride (Sigma)-loaded microspheres was used as a control in
microsphere experiments.
NO measurements.
NO production was assessed by measuring the
amount of nitrite in supernatants of BALF cell cultures, using the
Greiss reagent (30). The titer was determined using a
standard curve with serial dilutions of NaNO2 (Sigma) and
the detection limit was 3 µM per 105 cells.
Cell cultures.
BALF cells recovered from mice treated with
TDM-loaded microspheres were cultured in RPMI medium containing 10%
fetal calf serum (GIBCO-BRL, Grand Island, N.Y.), 10 mM HEPES, 20 mM
sodium bicarbonate, and penicillin and streptomycin (GIBCO-BRL) (100 µg/ml). In addition, resident peritoneal macrophages were
collected from naive mice by washing the peritoneal cavity with PBS and were cultured under the same conditions. Alternatively, resident peritoneal macrophages were layered onto a glass coverslip onto which 5 µl of purified TDM (Sigma) diluted in chloroform (1 mg/ml) was dropped and were allowed to dry. After incubation for 1 h in RPMI-1640 (Sigma) the coverslips were vigorously washed with the same medium and cultured in the presence of RPMI-1640 and 10%
fetal calf serum (Gibco-BRL). Coverslips were removed after 2, 4, or 8 days, and the supernatants were collected and kept at
70°C until assayed by ELISA. Cells were also analyzed by immunocytochemistry.
Immunocytochemistry.
TDM, LPS, and control lipid in
vitro-treated cells were fixed in 4% paraformaldehyde (Sigma). Slides
were washed with PBS, blocked, and incubated overnight at 4°C with
diluted monoclonal rat immunoglobulin G directed against IL-6, TNF-
,
and IL-10 or control isotype (Pharmingen) at a final concentration of 7 µg/ml. A biotinylated polyclonal rabbit anti-rat immunoglobulin G
diluted 1/100 was used as a secondary antibody. After washing, the
slides were stained by avidin-biotin complex peroxidase (Dako A/S,
Glostrup, Denmark). The chromogenic substrate was developed by
incubation in diaminobenzidine for 10 min. Finally, the slides were
stained with hematoxylin. For negative-control slides, all these steps were repeated, but with an irrelevant, isotype-matched or nonimmune serum substituted for the primary antibody.
Statistical analysis.
The results represent means ± standard deviations of the means. The significance of the difference
between groups was calculated by Dunnett's test. Computer-assisted
evaluation of the results was used to calculate the probability value
of the data. A P of 0.05 was used as the limit of
statistical significance.
 |
RESULTS |
Comparison of the inflammatory cell recruitment activity induced in
mice by M. tuberculosis and delipidated M. tuberculosis.
The number of total cells as well as
polymorphonuclear (PMN) and mononuclear (MN) cells in peritoneal fluid
measured 2, 8, and 16 days after injection of 3 × 106
viable M. tuberculosis or delipidated M. tuberculosis organisms into the peritoneal cavity of mice is shown
in Table 1. Inoculation of delipidated
M. tuberculosis significantly increased the number of
PMN cells in the peritoneal cavity up to 16 days after injection when
compared with the inoculation of intact M. tuberculosis
or with control groups receiving PBS, TDB, or a mixture of
triglycerides. In contrast, intense infiltrates of MN cells were
observed in the peritoneal cavity of mice inoculated with M. tuberculosis organisms or with the glycolipid DMT (Table 1). A
similar pattern of cell recruitment was also observed in lungs of
animals inoculated with delipidated M. tuberculosis or
with M. tuberculosis (data not shown).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Effect of TDM on the leukocyte cell influx into the
peritoneal cavity of mice several times after i.p. injection of
viable M. tuberculosis or delipidated M. tuberculosis
|
|
Inflammation, cytokines, and NO production induced by TDM-PLGA
microspheres.
To determine whether TDM induces inflammation,
cytokines, and NO production a drug delivery system based on
biodegradable microspheres was used. This system consists of
microparticles formed by a polymeric matrix where the lipid is
entrapped. The microparticles of PLGA (50:50) have a slow degradation
time, and thus the treated mice were sacrificed 60 days after treatment to ensure that most of the lipid was released (14). Mice
treated with TDM-loaded PLGA microspheres showed an intense infiltrate of MN cells in the lungs; however, control mice treated with TDB-loaded or unloaded PLGA microspheres were unable to induce an inflammatory reaction (data not shown). Levels of IL-6, TNF-
, IL-10, IFN-
, IL-12, and IL-4 found in homogenates of bulk lung cells from mice treated with TDM-PLGA microspheres presenting intense inflammatory reactions in the lungs were significantly higher than levels in PBS-treated mice (Fig. 1). In addition,
supernatants from cultures of BALF cells collected from animals treated
60 days before with TDM-PLGA microspheres showed higher levels of NO
production than with PBS (negative control) (Fig.
2).

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 1.
Levels of IL-6, TNF- , IL-10, IL-12, IL-4, and IFN-
determined by ELISA in the homogenate of bulk lung cells from mice
treated with TDM-PLGA microspheres or with encapsulated microspheres
containing lipids (CL) or TDB. Mice were killed 60 days after treatment
and cytokines were determined by ELISA. Data representing a typical
experiment repeated three times are expressed as means ± standard
deviations for five mice in each group. Asterisks indicate a
significant difference between the TDM-PLGA-injected and PBS control
groups (P < 0.01).
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 2.
NO levels in the supernatant culture of BALF cells
recovered from mice inoculated with TDM-PLGA microspheres or controls
as described for Fig. 1. The nitrite level was assayed as described in
Materials and Methods. Data representing a typical experiment repeated
three times are expressed as means ± standard deviations for five
mice in each group. Asterisks indicate a significant difference between
the experimental and PBS control groups (P < 0.01).
|
|
Inflammation induced by TDM-coated charcoal particles.
Intravenous administration of TDM coated to charcoal particles induced
an intense inflammatory reaction around the particles that were trapped
in the lungs, as shown in Fig. 3. This
reaction was more intense after 4 to 8 days, when it was detected
around approximately 80% of the particles. The histological picture of the lung inflammatory reaction around TDM-coated charcoal particles was characterized by several layers of large MN cells. Ninety-nine percent of uncoated particles or particles coated with lipid control were scored as negative at 2, 4, and 8 days postinoculation.

View larger version (120K):
[in this window]
[in a new window]
|
FIG. 3.
Mouse lung inflammatory reaction 4 (A), 8 (B),
and 16 (C) days after injection of charcoal particles coated with
TDM. Note the strong inflammatory reaction around the particles.
Charcoal particles without TDM (D) presented no inflammatory reaction 4 days after inoculation. Magnification, ×400.
|
|
Cytokines and NO production induced by TDM in macrophage
cultures.
Peritoneal macrophages were layered onto a glass
coverslip to which TDM was previously allowed to adhere. As shown in
Fig. 4, there was a clear migration of
cells toward the spot of TDM, a fact not observed for coverslips
containing TDB or a mixture of triglycerides as the control lipid.
Supernatants collected after 2 days of this culture presented higher
levels of IL-6, TNF-
, IL-10, IL-12, and IFN-
(Fig.
5) than supernatants obtained from
coverslips containing a mixture of triglycerides as a control lipid.
Similar data were also observed using immunocytochemistry analysis
(data not shown). Nitrite production was detected in the supernatant
of TDM-stimulated cultures 24 h after stimulation (data not
shown).

View larger version (147K):
[in this window]
[in a new window]
|
FIG. 4.
Migration of peritoneal macrophages toward the
center of a glass coverslip to which TDM was previously allowed to
adhere. Magnification, ×200.
|
|

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 5.
Levels of IL-6, TNF- , IL-10, IL-12, and IFN-
determined by ELISA in the culture supernatants of peritoneal
macrophages in the presence of TDM. Data representing a
typical experiment repeated three times are expressed as means ± standard deviations for five glass coverslips in each group which TDM
was previously allowed to adhere. Asterisks indicate a significant
difference between the experimental (cells stimulated with TDM or LPS)
and medium control groups (*, P < 0.05; **, P < 0.01).
|
|
 |
DISCUSSION |
TDM is a potent immunomodulator that increases nonspecific
resistance to infectious agents and limits tumor growth (12, 16,
20). Direct or indirect attraction of macrophages by TDM to the site of inoculation may be one component of its mechanism of
action. Other TDM action would be the priming of newly arrived macrophages at the site of inoculation (19). Our
results using either delipidated mycobacteria or microspheres showed
that TDM has an important role in recruitment of cells for granuloma
formation in tuberculosis and in modulation of expression or production of important immunological mediators, including cytokines and NO.
Treatment of viable M. tuberculosis cells with
petroleum ether solvent removed lipid substances from the outer cell
wall, and 90 to 95% of all bacilli (delipidated M. tuberculosis) continued to be viable after the extraction
procedure. The lipid extract was fractionated by column chromatography
(17, 28) and the TDM component was obtained, as shown by
physical and chemical analysis (31). The response of mice
to i.p. administration of live M. tuberculosis or
delipidated M. tuberculosis organisms was studied by
evaluating the influx of leukocytes into the peritoneal cavity. The
i.p. inflammatory picture induced by inoculation of delipidated
M. tuberculosis was drastically altered when compared with that induced by intact M. tuberculosis, especially
in terms of the nature of the reaction, the types of cells involved,
and the onset and duration of the inflammatory reaction. Inoculation with M. tuberculosis as well as delipidated
M. tuberculosis significantly increased the number of
inflammatory cells in the peritoneal cavity up to 16 days after
injection compared with the control group receiving only PBS, and the
number declined afterwards for delipidated M. tuberculosis-injected mice. The kinetics of cell recruitment induced by delipidated M. tuberculosis revealed an intense
increase in PMN from the beginning of infection that declined over 16 days. In contrast, the MN cell phase, beginning at 2 days and with a gradual increase over 16 days after injection, was observed for M. tuberculosis inoculation (Table 1). Treatment of
animals with TDM significantly increased the total cell numbers at 2 and 8 days after injection. When differential cell counts were
performed on these peritoneal washouts. MN cells showed the greatest
increase when compared to the cells of the control groups injected with control lipids (TDB or a mixture of triglycerides). As previously demonstrated (27), the lung inflammation induced by
inoculation of delipidated M. tuberculosis was also
significantly altered when compared to that induced by intact
M. tuberculosis. The lesion induced by delipidated
M. tuberculosis was characterized as an acute
inflammatory reaction, mainly because of the presence of PMN cells and
a small number of MN cells. A gradual decrease of the cellular
infiltrate occurred from the 4th day after inoculation onwards, with
disappearance of the infiltrate between the 16th and 32nd days
(27). The changes that occurred during the cell recruitment caused by delipidated M. tuberculosis in
relation to that caused by intact M. tuberculosis could
be related to the presence or absence of TDM at the reaction site.
Although TDM accounted for 90% of the residual material extracted with
petroleum ether from M. tuberculosis, the extraction
procedure also isolated several other lipid components, including
glycolipids, free mycolic acid, glycerides, menaquinones, and
hydrocarbons. The importance of these components in inducing the
inflammatory reaction will be investigated.
As far as multiplication of the organism is concerned, the tubercle
bacillus can grow in culture without TDM on its surface. Thus, TDM is
not essential for bacterial multiplication in vitro, although the
bacillus constantly synthesizes it (27). On the other
hand, TDM could be essential for bacillus multiplication in the host,
because it may protect the microorganism against destruction by
phagocytes (27, 29). Unprotected bacilli, i.e., bacilli
without the outer glycolipid layer, may undergo phagocytosis by
leukocytes and may be eliminated if there is not enough time to
synthesize a new lipid layer for protection against the destroying mechanisms of leukocytes. If the bacilli escape from destruction, they
can form a new protective lipid layer and behave as normal bacilli,
triggering the entire process of chronic tubercular lesions (25). We already demonstrated (27) that the
viability of microorganisms having no external lipid layer was
drastically reduced during the first 2 weeks after inoculation, and no
viable organisms were observed in any of the organs studied from the
20th day on. Microorganisms that had been previously delipidated and
then recomposed with TDM were able to survive and multiply in the
animals' organs in a manner similar to that observed for the intact
bacilli (27).
The data reported in the present paper suggest that the inflammatory
activity of TDM is important for the development of a specific immune
response to the tubercle bacillus, since it is responsible for the
recruitment and maintenance of a large number of activated
macrophages around the lesion, thus permitting these cells to
present antigens to T lymphocytes. As previously demonstrated (27), delayed-type hypersensitivity did not occur when
delipidated Mycobacterium bovis BCG was inoculated.
Delipidated bacilli induced an acute inflammatory reaction, and the
cells present at the lesion site, comprising predominantly PMN cells,
were unable to present antigens to T lymphocytes, and therefore no
animal sensitization to mycobacterial antigens occurred
(27).
In order to clarify the role of TDM in recruitment of inflammatory
cells and its capacity for priming or activating newly arrived
macrophages at the site of inoculation, we developed a model of
inflammatory reaction by injecting TDM-coated charcoal particles or TDM
encapsulated in PLGA microspheres. When TDM was adsorbed to charcoal
particles (50 to 100 µm in diameter) and inoculated into mice,
embolization of these particles occurred in the pulmonary circulation,
and typical epithelioid granulomas developed around them. A decreased
inflammatory reaction was observed around the charcoal particles in
lungs collected 16 days after inoculation, and the absence of lesions
was found on the 32nd day. These results suggest that progressive
elimination of TDM from these particles took place. If the duration of
the inflammatory process was related to TDM clearance, we could
speculate that the chronic development of granuloma, which contains
live bacilli, may derive from molecules of this glycolipid, which could
be constantly synthesized and could maintain the inflammatory process
by being transferred to the surface of the bacilli. The high intensity of inflammatory reactions induced in lungs of mice by administration of
TDM-PLGA microspheres was associated with high amounts of IL-6, TNF-
, IL-10, IFN-
, IL-12, and IL-4 observed in homogenates of bulk lung cells from these animals. Similar results were obtained in
vitro by stimulation of peritoneal macrophages with TDM.
Infection with M. tuberculosis leads to activation of
macrophages and lymphocytes and to granuloma formation
(18). Accumulation of inflammatory cells in the
presence of TDM occurs at the sites of infection, following cell
adhesion to endothelial cells and migration from blood vessels into
tissues. Cell-cell adhesion is essential for interaction of leukocytes
for granuloma formation, migration of cells through vessel walls, and
activation of the specific immune response against the pathogen.
Increased levels of expression of adhesion and costimulatory molecules
have been associated with increased cell adhesion and migration and
with activation of a specific immune response both in vivo and in vitro (11) and may be brought about by cytokines such as
TNF-
, IL-12, IL-6, IL-1, IFN-
, IL-2, and IL-4 (5, 6,
32). Cytokines are also involved in inflammation and antigen
presentation. IFN-
and IL-10 can induce up- and down-regulation of
costimulatory molecules, respectively (6, 32). Preliminary
results from our group have demonstrated that the level of CD11b, CD40,
and CD80 molecules in alveolar macrophages from M. tuberculosis-infected mice was higher than that observed in
delipidated M. tuberculosis-infected mice. The low
level of cytokine production associated with a small number of cells
expressing adhesion and costimulatory molecules in mice infected with
delipidated M. tuberculosis could suggest that lipids
in the mycobacterial cell wall are important in modulating the
inflammatory process.
NO was detected in supernatant cultures of BALF from mice treated with
TDM microspheres and in supernatant cultures of peritoneal macrophages treated in vitro with TDM. Our results
are in agreement with another study indicating that TDM induces NO
(8). On the other hand, several reports have previously
described the induction of the NO pathway in murine, rat, and human
macrophages after M. tuberculosis infection
(7, 15, 23). Therefore, our data using TDM microspheres in
vivo and peritoneal macrophages treated with TDM in vitro
suggest that TDM could be one of the bacterial components responsible
for this stimulation. The observation that the control glycolipid (TDB)
elicited a highly significant level of NO production is being investigated.
The capacity of macrophages to simultaneously secrete cytokines
and NO in vivo and in vitro after TDM stimulation suggests that TDM
could be of particular relevance for the immune response contribution
to inflammation. In addition, the cytokines induced by TDM have great
potential as immunomodulators and adjuvants in both infectious diseases
and cancer. We propose that cytokine inducers such as TDM may be
attractive candidates for therapeutic and adjuvant use in
experiments using DNA vaccine or gene therapy against tuberculosis.
 |
ACKNOWLEDGMENTS |
This study was supported by Fundação de Amparo
à Pesquisa do Estado de São Paulo (FAPESP) and Conselho
Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Immunology, School of Medicine of Ribeirão
Preto, University of São Paulo, 14049-900 Ribeirão Preto,
SP, Brazil. Phone: 55 16 602 3228. Fax: 55 16 633 6840. E-mail:
clsilya{at}fmrp.usp.br.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Albeda, S. M., and C. A. Bulk.
1990.
Integrins and other cell adhesion molecules.
FASEB J.
4:2868-2880[Abstract].
|
| 2.
|
Beckman, E. M.,
S. A. Porcelli,
C. T. Morita,
S. M. Behar,
S. T. Furlong, and M. B. Brenner.
1994.
Recognition of a lipid antigen by CD1-restricted  + T cells.
Nature
372:691-694[CrossRef][Medline].
|
| 3.
|
Behling, C. A.,
R. L. Perez,
M. R. Kidd,
G. W. Staton, Jr., and R. L. Hunter.
1993.
Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids.
Ann. Clin. Lab. Sci.
23:256-266[Abstract].
|
| 4.
|
Bloch, H.
1950.
Studies on the virulence of tubercle bacilli. Isolation and biological properties of constituent of virulent organisms.
J. Exp. Med.
91:197-217[Abstract].
|
| 5.
|
Creery, W. D.,
F. Diaz-Mitoma,
L. Filion, and A. Kumar.
1996.
Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype.
Eur. J. Immunol.
26:1273-1277[Medline].
|
| 6.
|
Freedman, A. S.,
G. J. Freeman,
K. Rhynhart, and L. M. Nadler.
1991.
Selective induction of B7/BB-1 on interferon gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway.
Cell. Immunol.
137:429-437[CrossRef][Medline].
|
| 7.
|
Greenberg, S. S.,
J. Xie,
J. Kolls,
C. Manson, and P. Didier.
1995.
Rapid induction of mRNA for nitric oxide synthase II in rat alveolar macrophage by intratracheal administration of Mycobacterium tuberculosis and Mycobacterium avium.
Proc. Soc. Exp. Biol. Med.
209:46-53[CrossRef][Medline].
|
| 8.
|
Guillemard, E.,
M. Geniteau-Legendre,
R. Kergot,
G. Lemaire,
S. Gessani,
C. Labarre, and A. M. Quero.
1998.
Simultaneous production of IFN- , IFN- / and nitric oxide in peritoneal macrophages from TDM-treated mice.
J. Biol. Regul. Homeost. Agents
12:106-111[Medline].
|
| 9.
|
Haagmans, B. L.,
A. J. van den Eertwegh,
E. Claassen,
M. C. Horzinek, and V. E. Schijns.
1994.
Tumor necrosis factor-alpha production during cytomegalovirus infection in immunosuppressed rats.
J. Gen. Virol.
75:779-787[Abstract/Free Full Text].
|
| 10.
|
Koike, Y.,
Y. C. Yoo,
M. Mitobe,
T. Oka,
K. Okuma,
S. Tono-oka, and I. Azuma.
1998.
Enhancing activity of mycobacterial cell derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.
Vaccine
16:1982-1989[CrossRef][Medline].
|
| 11.
|
Larson, S., and T. A. Springer.
1990.
Structure and function of leukocyte integrins.
Immunol. Rev.
114:181-217[CrossRef][Medline].
|
| 12.
|
Lemaire, G.,
J. P. Tenu,
J. F. Petit, and E. Lederer.
1986.
Natural and synthetic trehalose diesters as immunomodulators.
Med. Res. Rev.
6:243-247[CrossRef][Medline].
|
| 13.
|
Lewis, D. H.
1990.
Controlled release of bioactive agents from lactide/glycolide polymers, p. 1-43.
In
M. Chasin, and R. Langer (ed.), Biodegradable polymers as drug delivery systems. Marcel Dekker, New York, N.Y.
|
| 14.
|
Lima, K. M., and J. M. Rodrigues Júnior.
1999.
Poly-DL-lactide-co-glycolide microspheres as a controlled release antigen delivery system.
Braz. J. Med. Biol. Res.
32:171-180[Medline].
|
| 15.
|
Nabeshima, S.,
M. Nomoto,
G. Matsuzaki,
K. Kishihara,
H. Taniguchi,
S. Yoshida, and K. Nomoto.
1999.
T-cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis.
Infect. Immun.
67:3221-3226[Abstract/Free Full Text].
|
| 16.
|
Nolibe, D.,
R. Masse,
J. P. Tenu,
M. Lepoivre, and J. F. Petit.
1986.
Activation of rat alveolar macrophages and protection against i.v. injected tumor cells by intratracheal administration of trehalose dimycolate.
Cancer Immunol. Immunother.
23:200-206[Medline].
|
| 17.
|
Noll, H.,
H. Bloch,
J. Asselineau, and E. Lederer.
1956.
The chemical structure of the cord factor of Mycobacterium tuberculosis.
Biochim. Biophys. Acta
20:299-309[Medline].
|
| 18.
|
Orme, I. M., and A. M. Cooper.
1999.
Cytokine/chemokine cascades in immunity to tuberculosis.
Immunol. Today
7:307-312.
|
| 19.
|
Oswald, I. P.,
S. Afround,
D. Bray,
J. F. Petit, and G. Lemaire.
1992.
Low response of BALB/c macrophages to priming and activating signals.
J. Leukoc. Biol.
52:315-322[Abstract].
|
| 20.
|
Parant, M.,
F. Parant,
L. Chedid,
J. C. Drapier,
J. F. Petit,
J. Wietzerbin, and E. Lederer.
1977.
Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6'-trehalose dimycolate).
J. Infect. Dis.
135:771-777[Medline].
|
| 21.
|
Retzinger, G. S.,
S. C. Meredith,
R. L. Hunter,
K. Takayama, and F. J. Kézdy.
1982.
Identification of the physiologically active state of the mycobacterial glycolipid trehalose 6,6'-dimycolate and the role of fibrinogen in the biologic activities of trehalose 6,6'-dimycolate monolayers.
J. Immunol.
129:735-744[Medline].
|
| 22.
|
Ribi, E.,
D. L. Granger,
K. C. Milner,
K. Yamamoto,
S. M. Strain,
R. Parker,
R. W. Smith,
W. Brehmer, and I. Azuma.
1982.
Induction of resistance to tuberculosis in mice with defined components of mycobacteria and some unrelated materials.
Immunology
46:297-305[Medline].
|
| 23.
|
Rich, E. A.,
M. Torres,
E. Sada,
C. K. Finegan,
B. D. Hamilton, and Z. Toossi.
1997.
Mycobacterium tuberculosis (Mtb)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of Mtb.
Tuber. Lung Dis.
78:247-255[CrossRef][Medline].
|
| 24.
|
Rook, G. A. W., and R. Hernandez-Pando.
1996.
The pathogenesis of tuberculosis.
Annu. Rev. Microbiol.
50:259-284[CrossRef][Medline].
|
| 25.
|
Silva, C. L.
1985.
Inflammation induced by micolic acid-containing glycolipids of Mycobacterium bovis (BCG).
Braz. J. Med. Biol. Res.
18:327-335[Medline].
|
| 26.
|
Silva, C. L., and S. M. Ekizlerian.
1985.
Granulomatous reactions induced by lipids extracted from Fonsecaea pedrosi, Fonsecaea compactum, Cladasporium carrionii and Phialophora verrucosum.
J. Gen. Microbiol.
131:187-194[Abstract/Free Full Text].
|
| 27.
|
Silva, C. L.,
S. M. Ekizlerian, and R. A. Fazioli.
1985.
Role of cord factor in the modulation of infection caused by Mycobacteria.
Am. J. Pathol.
118:238-247[Abstract].
|
| 28.
|
Silva, C. L., and L. H. Faccioli.
1988.
Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria.
Infect. Immun.
56:3067-3071[Abstract/Free Full Text].
|
| 29.
|
Spargo, B. J.,
L. M. Crowe,
T. Ioneda,
B. L. Beaman, and J. H. Crowle.
1991.
Cord factor ( , -trehalose 6-6'-dimycolate) inhibits fusion between phospholipid vesicles.
Proc. Natl. Acad. Sci. USA
88:737-740[Abstract/Free Full Text].
|
| 30.
|
Stuehr, D. J., and C. F. Nathan.
1989.
Nitric oxide. A macrophage product responsible for cystostasis and respiratory inhibition in tumor target cells.
J. Exp. Med.
169:1543-1555[Abstract/Free Full Text].
|
| 31.
|
Thomas, D. W.,
A. K. Matida,
C. L. Silva, and T. Ioneda.
1979.
Esters of trehalose from Corynebacterium diphtheriae: a modified purification procedure and studies on the structure of their constituent hydroxylated fatty acids.
Chem. Phys. Lipids
23:267-282[CrossRef].
|
| 32.
|
Willems, F.,
A. Marchant,
J. P. Delville,
C. Gerard,
A. Delvaux,
T. Velu,
M. de Boer, and M. Goldman.
1994.
Interleukin-10 inhibits B7 and intercellular adhesion molecule 1 expression on human monocytes.
Eur. J. Immunol.
24:1007-1009[Medline].
|
Infection and Immunity, September 2001, p. 5305-5312, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5305-5312.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Guidry, T. V., Hunter, R. L. Jr, Actor, J. K.
(2007). Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes. Microbiology
153: 3360-3369
[Abstract]
[Full Text]
-
Frantz, F. G., Rosada, R. S., Turato, W. M., Peres, C. M., Coelho-Castelo, A. A. M., Ramos, S. G., Aronoff, D. M., Silva, C. L., Faccioli, L. H.
(2007). The Immune Response to Toxocariasis Does Not Modify Susceptibility to Mycobacterium tuberculosis Infection in BALB/c Mice. Am J Trop Med Hyg
77: 691-698
[Abstract]
[Full Text]
-
Guidry, T. V., Hunter, R. L. Jr, Actor, J. K.
(2006). CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate in mice. Microbiology
152: 3765-3775
[Abstract]
[Full Text]
-
Hunter, R. L., Olsen, M. R., Jagannath, C., Actor, J. K.
(2006). Multiple Roles of Cord Factor in the Pathogenesis of Primary, Secondary, and Cavitary Tuberculosis, Including a Revised Description of the Pathology of Secondary Disease. Annals of Clinical & Laboratory Science
36: 371-386
[Abstract]
[Full Text]
-
Geisel, R. E., Sakamoto, K., Russell, D. G., Rhoades, E. R.
(2005). In Vivo Activity of Released Cell Wall Lipids of Mycobacterium bovis Bacillus Calmette-Guerin Is Due Principally to Trehalose Mycolates. J. Immunol.
174: 5007-5015
[Abstract]
[Full Text]
-
Holten-Andersen, L., Doherty, T. M., Korsholm, K. S., Andersen, P.
(2004). Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines. Infect. Immun.
72: 1608-1617
[Abstract]
[Full Text]
-
Converse, S. E., Mougous, J. D., Leavell, M. D., Leary, J. A., Bertozzi, C. R., Cox, J. S.
(2003). MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. USA
100: 6121-6126
[Abstract]
[Full Text]
-
Russell, D. G., Mwandumba, H. C., Rhoades, E. E.
(2002). Mycobacterium and the coat of many lipids. JCB
158: 421-426
[Abstract]
[Full Text]